Under the partnership, Cigna will provide two years of medical claims data to ASAM and BrandeisUniversity researchers, who will analyze which treatment methodologies were the most effective.
Cigna expects researchers to complete the claims analysis this fall. The study will be funded in part by the National Institute on Alcohol Abuse and Alcoholism.
“We can drill down in the data and develop some predictive models,” William Lopez, MD, Cigna’s senior medical director, told Forbes. “This is a chronic disease and they may struggle with this for years. We can use this data to better manage [their care].”
More articles on payer issues:
UnitedHealthcare, Obstetrix contract impasse leaves patients without coverage
La. Medicaid program renamed ‘Healthy Louisiana’
BCBS of Illinois will stop accepting credit card payments
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
